Intraoral Administration of Botulinum Toxin for Continuous Dentoalveolar Neuropathic Pain: A Case Series.

CONCLUSION: These results suggest the potential therapeutic benefit of BoNT/A in the management of continuous dentoalveolar neuropathic pain. Further investigations conducted via well-controlled studies in the area of orofacial pain are warranted. PMID: 30726860 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30726860?dopt=Abstract

Source: Journal of Orofacial Pain - February 7, 2019 Category: ENT & OMF Tags: J Oral Facial Pain Headache Source Type: research